メッセンジャーリボ核酸（mRNA）合成原料の世界市場レポート 2025年

メッセンジャーリボ核酸（mRNA）合成原料の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR3.7％で35億4,000万米ドルに成長します。予測期間の成長は、サプライチェーンの最適化、商業化と市場の拡大、バイオテクノロジーと製薬への投資、規制当局のサポートと承認、治療法の拡大に起因すると考えられます。予測期間の世界の動向には、新規参入企業の出現、品質管理と標準化、知的財産とライセンシング、世界アクセスと公平性、持続可能でスケーラブルな製造へのシフトなどが含まれます。

がんと慢性疾患の有病率の上昇は、今後のmRNA合成原料市場の成長を促進すると予想されます。がんは、制御不能な異常細胞の増殖を特徴とし、周囲の組織に浸潤し、血液やリンパ系を通じて身体の他の部分に広がる可能性があります。慢性疾患は一般的に、1年以上持続し、継続的な治療を必要とし、日常生活に支障をきたす、またはその両方の状態を指します。mRNA合成のための原料は、創薬、ワクチン開発、RNAベースの治療薬の製造に利用され、がんや慢性疾患の治療のために免疫原性を高め、効率を改善し、製造時間を短縮します。例えば、米国を拠点とする健康団体American Cancer Society Facts and Figuresによると、2022年に米国で新たにがんと診断された患者数は190万人と推定され、60万9360人が死亡しました。2023年の予測では、新規症例数は190万人以上、死亡者数は約60万9820人と、わずかに増加する見込みです。したがって、がんと慢性疾患の発生率の上昇がmRNA合成原料の需要を牽引しています。

mRNA技術を支援する政府のイニシアチブは、mRNA合成原料市場の成長を促進する態勢を整えています。こうした取り組みには、メッセンジャーRNA（mRNA）技術の研究開発および応用を促進するための政府機関による協調的な取り組み、プログラム、政策、財政的支援が含まれます。このような政府の支援は、資金、インフラ、規制の裏付け、世界の協力の機会を提供することで、mRNA合成原料市場にとって好都合な環境を作り出しています。2023年2月現在、BMJ誌は米国政府がパンデミック後のmRNA COVID-19ワクチンに319億米ドルを投資したと報告しています。財政的支援にもかかわらず、ファイザー・バイオンテックやモデナといった企業のmRNAワクチンのコストは、ワクチン価格設定の進化を反映し、時間の経過とともに上昇していることは注目に値します。具体的には、ファイザー・バイオンテック社のワクチンの1回当たりの価格は、2020年の19.50ドルから2022年には2価ブースターの30.48ドルに上昇し、モデナ社のコストは2020年の1回当たり15.25ドルから2022年には26.36ドルに上昇しました。したがって、mRNA技術に対する政府のイニシアチブは、mRNA合成原料市場の成長を促進する上で極めて重要な役割を果たしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界メッセンジャーリボ核酸（mRNA）合成原料PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場：成長率分析
• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場の実績：規模と成長, 2019-2024
• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場の予測：規模と成長, 2024-2029, 2034F
• 世界メッセンジャーリボ核酸（mRNA）合成原料総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• キャッピング剤
• ヌクレオチド
• プラスミドDNA
• その他のタイプ
• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療薬製造
• ワクチン製造
• その他の用途
• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオテクノロジー企業
• 製薬会社
• 調査・学術機関
• その他のエンドユーザー
• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場、キャッピング剤のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 7-メチルグアニル酸（M7G）キャッピング剤
• その他のキャッピング剤
• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場ヌクレオチドの種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 天然ヌクレオチド
• 修飾ヌクレオチド
• 三リン酸ヌクレオチド
• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場、プラスミド DNAのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 線状化プラスミドDNA
• 環状プラスミドDNA
• 高純度プラスミドDNA
• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 緩衝液
• 酵素
• その他の補助材料

第7章 地域別・国別分析

• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のメッセンジャーリボ核酸（mRNA）合成原料市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• メッセンジャーリボ核酸（mRNA）合成原料市場：競合情勢
• メッセンジャーリボ核酸（mRNA）合成原料市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Lonza Group Ltd.
• Eurofins Scientific
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Maravai LifeSciences
• Takara Bio Inc.
• GenScript Biotech Corporation
• Promega Corporation
• Abcam plc
• BioLegend Inc.
• Integrated DNA Technologies Inc.
• Sino Biological Inc.
• CureVac N.V.
• LGC Biosearch Technologies
• Enzo Biochem Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• メッセンジャーリボ核酸（mRNA）合成原料市場2029：新たな機会を提供する国
• メッセンジャーリボ核酸（mRNA）合成原料市場2029：新たな機会を提供するセグメント
• メッセンジャーリボ核酸（mRNA）合成原料市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Messenger ribonucleic acid (mRNA) synthesis raw materials comprise ribonuclear components crucial for the precise and efficient creation of mRNA molecules in in-vitro transcription procedures, facilitating the production of functional synthetic RNAs. These materials play a pivotal role in generating mRNA vaccines that trigger the body's immune system to produce a defense response against specific antigens, thereby enhancing overall immune capacity.

Key components of mRNA synthesis raw materials encompass capping agents, nucleotides, plasmid DNA, among others. Capping agents, for instance, are amphiphilic molecules featuring a polar head group and a non-polar hydrocarbon tail. These agents are utilized in introducing modified cap structures to mRNA molecules during synthesis, imparting stability and protection to the mRNA. This enhances translation efficiency and fortifies the mRNA against degradation. These materials find diverse applications in therapeutics and vaccine production and are commonly employed by biotechnology firms, pharmaceutical companies, research institutions, and similar entities.

The mRNA synthesis raw materials market research report is one of a series of new reports from The Business Research Company that provides mRNA synthesis raw materials market statistics, including mRNA synthesis raw materials industry global market size, regional shares, competitors with mRNA synthesis raw materials market share, detailed mRNA synthesis raw materials market segments, market trends, and opportunities, and any further data you may need to thrive in the mRNA synthesis raw materials industry. This mRNA synthesis raw materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The messenger ribonucleic acid (mRNA) synthesis raw materials market size has grown steadily in recent years. It will grow from $2.99 billion in 2024 to $3.06 billion in 2025 at a compound annual growth rate (CAGR) of 2.5%. The growth in the historic period can be attributed to biomedical research advancements, rising interest in vaccines and therapeutics, demand for personalized medicine, outbreak preparedness and response, and biotech industry growth

The messenger ribonucleic acid (mRNA) synthesis raw materials market size is expected to see steady growth in the next few years. It will grow to $3.54 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to supply chain optimization, commercialization and market expansion, investments in biotech and pharma, regulatory support and approvals, and therapeutic expansion. Major trends in the forecast period include the emergence of new entrants, quality control and standardization, intellectual property and licensing, global access and equity, shift towards sustainable and scalable manufacturing.

The rising prevalence of cancer and chronic disorders is anticipated to drive the growth of the mRNA synthesis raw materials market in the future. Cancer is characterized by the uncontrolled growth of abnormal cells that can invade surrounding tissues and potentially spread to other parts of the body through the blood and lymphatic systems. Chronic disorders are generally defined as conditions that last for a year or longer, require ongoing medical treatment, hinder daily activities, or both. Raw materials for mRNA synthesis are utilized in drug discovery, vaccine development, and the production of RNA-based therapeutics to enhance immunogenicity, improve efficiency, and shorten production times for treating cancer and chronic diseases. For example, according to the American Cancer Society Facts and Figures, a US-based health organization, an estimated 1.9 million new cancer cases were diagnosed in the US in 2022, resulting in 609,360 deaths. Projections for 2023 indicate a slight increase to over 1.9 million new cases and approximately 609,820 deaths. Therefore, the rising incidence of cancer and chronic disorders is driving the demand for mRNA synthesis raw materials.

Government initiatives supporting mRNA technology are poised to drive the growth of the mRNA synthesis raw materials market. These initiatives encompass coordinated efforts, programs, policies, and financial backing by governmental entities to promote research, development, and application of Messenger RNA (mRNA) technology. Such government support creates a conducive environment for the mRNA synthesis raw materials market by providing funding, infrastructure, regulatory backing, and opportunities for global collaboration. As of February 2023, The BMJ reported that the US government has invested $31.9 billion in mRNA COVID-19 vaccines post-pandemic. Despite financial support, it is noteworthy that the costs for mRNA vaccines from companies such as Pfizer-BioNTech and Moderna have increased over time, reflecting the evolving landscape of vaccine pricing. Specifically, the pricing per dose for Pfizer-BioNTech's vaccine increased from $19.50 in 2020 to $30.48 for the bivalent booster in 2022, while Moderna's costs rose from $15.25 per dose in 2020 to $26.36 in 2022. Hence, government initiatives for mRNA technology play a pivotal role in propelling the growth of the mRNA synthesis raw materials market.

The mRNA synthesis raw materials market is witnessing a notable trend with the increasing emphasis on product innovations. Key players in this market are strategically focusing on the development of innovative products to enhance their market positioning. An illustrative example is Thermo Fisher Scientific, a prominent US-based company specializing in instrumentation, reagents, consumables, and software services. In September 2022, the company introduced Dynabeads Solutions, a revolutionary bead designed for scaling GMP-grade synthesis and purification of mRNA for vaccine development. The Dynabeads Streptavidin for In Vitro Transcription facilitates solid-phase IVT of cell-free mRNA, enabling the reuse of the DNA template up to six times. This innovation not only streamlines the plasmid creation process but also enhances mRNA yield on scales ranging from grams to grams. Consequently, it supports the development of a streamlined pipeline, enabling mRNA firms to expedite the transition from development to commercialization.

Major players in the mRNA synthesis raw materials market are actively engaged in the development of raw materials to boost their profitability and market share. Innovations in raw materials and their quality play a pivotal role in enhancing the efficiency, yield, and safety of mRNA synthesis processes, thereby influencing the overall success of applications in biotechnology and medicine. As an instance, in September 2022, TriLink BioTechnologies, a prominent US-based biotechnology company, introduced N1-Methyl-Pseudouridine-5'-Triphosphate, a crucial raw material in the production of various mRNA drugs. This innovative product facilitates accelerated drug discovery, meeting the rising demand for N1-methyl-pseudouridine modified mRNA. TriLink BioTechnologies' commitment to providing unmatched analytical capabilities and GMP-grade offerings underscores its dedication to advancing groundbreaking mRNA-based therapies globally.

In January 2022, Maravai LifeSciences, a United States-centered life sciences enterprise, completed the acquisition of MyChem for $240 million. This strategic acquisition is geared towards enhancing Maravai LifeSciences' array of nucleic acid production offerings and expediting its research and development capacities. MyChem, a company situated in the US, specializes in the manufacturing of nucleotides, making this acquisition a significant move for Maravai's expansion within this sector.

Major companies operating in the messenger ribonucleic acid (mRNA) synthesis raw materials market include Pfizer Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Moderna Inc., Agilent Technologies Inc., Lonza Group Ltd., Eurofins Scientific, Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Integrated DNA Technologies Inc., Sino Biological Inc., CureVac N.V., LGC Biosearch Technologies, Enzo Biochem Inc, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc, Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.

North America was the largest region in the mRNA synthesis raw materials market in 2024. The regions covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The mRNA synthesis raw materials market consists of sales of modified ribonucleoside triphosphates, polynucleotide tails, ribonucleoside diphosphate (NDPs), ribonucleoside monophosphate (NMPs), and ribonucleoside triphosphate (NTTs). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on messenger ribonucleic acid (mrna) synthesis raw materials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for messenger ribonucleic acid (mrna) synthesis raw materials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The messenger ribonucleic acid (mrna) synthesis raw materials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Capping Agents; Nucleotides; Plasmid DNA; Other Types
• 2) By Applications: Therapeutics Production; Vaccine Production; Other Applications
• 3) By End-Users: Biotechnology Companies; Pharmaceutical Companies; Research And Academic Institutions; Other End-Users
• Subsegments:
• 1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents; Other Capping Agents
• 2) By Nucleotides: Natural Nucleotides; Modified Nucleotides; Triphosphate Nucleotides
• 3) By Plasmid DNA: Linearized Plasmid DNA; Circular Plasmid DNA; High-Purity Plasmid DNA
• 4) By Other Types: Buffer Solutions; Enzymes; Other Auxiliary Materials
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Moderna Inc.; Agilent Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Characteristics

3. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Trends And Strategies

4. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Growth Analysis And Strategic Analysis Framework

• 5.1. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Growth Rate Analysis
• 5.4. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Total Addressable Market (TAM)

6. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Segmentation

• 6.1. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capping Agents
• Nucleotides
• Plasmid DNA
• Other Types
• 6.2. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutics Production
• Vaccine Production
• Other Applications
• 6.3. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotechnology Companies
• Pharmaceutical Companies
• Research And Academic Institutions
• Other End-Users
• 6.4. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Sub-Segmentation Of Capping Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7-Methyl Guanylate (M7G) Capping Agents
• Other Capping Agents
• 6.5. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Sub-Segmentation Of Nucleotides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Nucleotides
• Modified Nucleotides
• Triphosphate Nucleotides
• 6.6. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Sub-Segmentation Of Plasmid DNA, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Linearized Plasmid DNA
• Circular Plasmid DNA
• High-Purity Plasmid DNA
• 6.7. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buffer Solutions
• Enzymes
• Other Auxiliary Materials

7. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Regional And Country Analysis

• 7.1. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 8.1. Asia-Pacific Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 9.1. China Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• 9.2. China Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 10.1. India Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 11.1. Japan Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• 11.2. Japan Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 12.1. Australia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 13.1. Indonesia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 14.1. South Korea Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• 14.2. South Korea Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 15.1. Western Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• 15.2. Western Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 16.1. UK Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 17.1. Germany Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 18.1. France Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 19.1. Italy Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 20.1. Spain Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 21.1. Eastern Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• 21.2. Eastern Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 22.1. Russia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 23.1. North America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• 23.2. North America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 24.1. USA Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• 24.2. USA Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 25.1. Canada Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• 25.2. Canada Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 26.1. South America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• 26.2. South America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 27.1. Brazil Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 28.1. Middle East Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• 28.2. Middle East Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

• 29.1. Africa Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview
• 29.2. Africa Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Competitive Landscape And Company Profiles

• 30.1. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Competitive Landscape
• 30.2. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Other Major And Innovative Companies

• 31.1. Lonza Group Ltd.
• 31.2. Eurofins Scientific
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Qiagen N.V.
• 31.5. Maravai LifeSciences
• 31.6. Takara Bio Inc.
• 31.7. GenScript Biotech Corporation
• 31.8. Promega Corporation
• 31.9. Abcam plc
• 31.10. BioLegend Inc.
• 31.11. Integrated DNA Technologies Inc.
• 31.12. Sino Biological Inc.
• 31.13. CureVac N.V.
• 31.14. LGC Biosearch Technologies
• 31.15. Enzo Biochem Inc

32. Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

34. Recent Developments In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

35. Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market High Potential Countries, Segments and Strategies

• 35.1 Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer